[Beta-carotene treatment of protoporphyrias and polymorphic light dermatoses].
D016644:Canthaxanthin; D002338:Carotenoids / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010787:Photosensitivity Disorders / Q000188:drug therapy*; D011164:Porphyrias / Q000188:drug therapy*; D011166:Porphyrins / Q000097:blood*; D011524:Protoporphyrins / Q000097:blood*; D012871:Skin Diseases / Q000188:drug therapy*; D019207:beta Carotene
D011166:Porphyrins; D011524:Protoporphyrins; D019207:beta Carotene; D002338:Carotenoids; D016644:Canthaxanthin
beta-Carotin in der Behandlung von Protoporphyrien und polymorphen Lichtdermatosen.